What changes
the biology?
Investigate disease-relevant molecular interactions and the evidence connecting a target to a therapeutic hypothesis. Prioritize a clear mechanistic rationale and experiments that can challenge it.
Research
Our research direction centers on the relationship between molecular structure, biological function, and therapeutic potential.
Research priorities
Investigate disease-relevant molecular interactions and the evidence connecting a target to a therapeutic hypothesis. Prioritize a clear mechanistic rationale and experiments that can challenge it.
Explore molecular design as a balance of properties. Study how structure, selectivity, and developability can inform the choice of which ideas to test next.
Connect model uncertainty to experimental design. Favor experiments that resolve important unknowns, including results that disprove an appealing hypothesis.
A disciplined path
Computational predictions are starting points for research. Experimental validation, preclinical development, and clinical evaluation are distinct steps with different standards of evidence.
This website describes our scientific direction. Specific drug programs, development stages, and results will be shared when they are ready for disclosure.
AI can help connect evidence, explore molecular possibilities, and prioritize hypotheses. Scientists remain responsible for interpreting predictions and designing the experiments that test them.
No. A prediction does not demonstrate that a molecule is safe or effective. Those claims require appropriate experimental and clinical evidence.
Program-level information is not currently published here. Use the partnership page to prepare an introduction around a target, scientific question, or collaboration opportunity.